Morningstar Investor users sign in here.

Video

Best ways to invest while saving for a house deposit

Trying to invest for the short term? Don't bet the house on it!


Your questions answered:

In this episode of Q&A, your way, Morningstar's Sarah Dowling explains why investing for the short term comes with risks, especially if you're seeking returns above inflation. 

Key Points: 

  • Achieving returns above inflation are a steep ask at the moment, with the latest CPI rising to 7.8% over the year to the December quarter. RBA forecasts see headline inflation subsiding to 4.75% by end-2023.
  • Government bonds are considered to be less risky than equities, but the yield on a two-year treasury is currently around 3.1%. Bonds can also lose money over the short-term as we learned in 2022.
  • With a two-year time frame, the safest option a savings account or term deposit, with competitive interest rates around the mid-4% range.
  • Eligible first-home buyers may also be able to save for a deposit through their super fund, through the First Home Super Saver Scheme, although there are limitations on how much you can contribute each year. More information on the scheme, and other government measures for first-home buyers can be found on the Treasury website.

Transcript: 

Sarah Dowling: [Reading the question] We recently migrated to Australia, and don't know much about investment options here. We have roughly 80K sitting in a savings account that keeps losing value against inflation. We have two more years until we get permanent residency, and then we'll aim to purchase a property. I'm looking for non-risky investment options, which yield over inflation. I've checked out government and corporate bonds, but most of them have three to five plus years maturity. What are your recommendation?

Answer: The issue here is really about time frame. Two years is a very short period to be investing, especially in the share market and achieving returns above inflation at the moment is an incredibly tough ask, particularly because the latest CPI puts annual inflation at more than 7%. That is expected to subside. But even still by the end of the year RBA forecast put inflation at about 4.75%. So let's look at some options here.

So the really great thing here is that you've got a financial goal that you're aiming towards. If that time frame was longer, then the goal of achieving over inflation would become more achievable. You'd also have more options available there without taking on so much risk. We are in a period of high uncertainty at the moment. There's a lot of volatility in the market. And so investing your entire house deposit into shares may not be the best option for you.

Bonds are considered a lower risk than shares, but having said that, the yield on a 2 year treasury is in the low 3s at the moment. So in this situation, the safest option is really to park your cash in the bank, either in a savings or a term deposit account. Interest rates have improved recently, having said that there is a big gap between the lowest and the highest interest rates for savers at the moment, so make sure that you are doing that comparison.

The key thing here really is around your time frame and your situation, whether you need to buy that property within the two year period or if you can push out a little bit further, that will open up more investment opportunities and potentially mean that you can beat that rate of inflation. And remember all investments have a risk component. So your time frame is really important in determining what level of risk you're prepared to take.



© 2023 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.

More from Morningstar

Bank results: the winners and losers
Video

Bank results: the winners and losers

Morningstar analyst Nathan Zaia explains how the banks did and what the future holds.
How to deal with financial stress
Video

How to deal with financial stress

More high-income earners are now also experiencing financial stress. We go through practical ways to reduce it
UniSuper CIO John Pearce on why the 60/40 portfolio is far from dead
Video

UniSuper CIO John Pearce on why the 60/40 portfolio is far from dead

The $130 Billion SuperFund Manager also talks about how he sees risk, his recent investments, and why history isn’t a good guide to the future.
Incitec Pivot: explosive upside ahead?
Video

Incitec Pivot: explosive upside ahead?

Morningstar analyst Mark Taylor believes imminent growth in explosives earnings could lift sentiment.
Why Morningstar see opportunities in coal stocks
Video

Why Morningstar see opportunities in coal stocks

Analyst Jon Mills explains why he’s recently increased fair value estimates for Australian coal companies.
Is the sharp fall in ResMed's share price justified?
Video

Is the sharp fall in ResMed's share price justified?

The potential for weight loss drugs to impact the sleep apnea giant has weighed on the share price, though Morningstar analyst Shane Ponraj thinks...